Form 4: Tyra Biosciences Director Nina S. Kjellson Acquires Stock Options

Director Nina S. Kjellson acquired 18,600 stock options in Tyra Biosciences, Inc. on May 29, 2024, as part of the Non-Employee Director Compensation Program.

Summary

• Nina S. Kjellson, a director of Tyra Biosciences, Inc., acquired 18,600 stock options on May 29, 2024.
• The options were granted as part of the Issuer's Non-Employee Director Compensation Program.
• The exercise price of the stock options is $15.94.
• The options vest monthly, with 1/12th of the total shares vesting each month following the grant date.
• Any remaining unvested portion of the option will vest on the date of the next occurring annual meeting of the Issuer's stockholders if it occurs before the first anniversary of the grant date, subject to continuous service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects a standard compensation practice that aligns director interests with shareholder value. There are no indications of negative events or concerns.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Future Outlook

The director's holdings will increase as the options vest over time, assuming continued service to the company.

Industry Context

Stock option grants are a common form of compensation for directors, aligning their interests with the long-term success of the company. This is a standard practice in the biotech industry to attract and retain qualified board members.

Comparison to Industry Standards

• Director compensation packages, including stock options, are common in the biotechnology industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their director compensation programs.
• The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term commitment and performance.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates